We've all been griping for who knows how long virtually insurance companies messing with our coverage, confining access to needed medications and supplies and prioritizing net over patient wellness.

Their complex procedures force us to spend maddening amounts of time chasing after answers and pleading our cases connected why these prescriptions are necessity.

It's no surprise that our doctors and educators are facing the duplicate hurdles, and rest secure that #DiabetesAccessMatters to them almost arsenic overmuch it does to us along the patient side.

That's why our Diabetes Biotic community is working on a new initiative to bring the patient role and supplier community voices together to call for change. A group of diabetes advocates is working with some directing health care professionals to craft a template letter that patients and HCPs lav use together to approach insurers.

This effort echoes the broader #PrescriberPrevails movement occurrence crosswise the U.S., calling for Greco-Roman deity professionals' perspicacity to be trusted instead of second-guessed by insurance companies. Thither are even specific policies materializing in places wish New York, where a state practice of law's been adoptive Re: doctors determinative the best treatments for Medicaid patients.

The diabetes-specific letter being developed is a bring up in progress, that bequeath be launched more formally later in the year. A admonisher of the backstory here:

In English hawthorn 2016, Medtronic announced a deal with UnitedHealthcare making their insulin pumps the "preferred brand" for everyone covered by that insurance. While umpteen known that this wasn't the first favorite system and wouldn't be the last, it lit a send away under our D-Community advocacy efforts to take a stand for patient and provider choice.

Advocates elevated our voices, launching the hashtag #DiabetesAccessMatters, and within few months the Diabetes Patient Advocacy Alliance (DPAC) brought a number of us together past ring for a strategy session, that led to the realization and stem:

Our patient community can't really affect change without our medical professionals, and they look the assonant way. We need to coalesce forces for impact!

Thanks to DPAC, we PWDs (people with diabetes) now have a one-stop betray to send form letters to various insurance execs. But the doctors and educators don't have a standardised resource…

Distinctly, they're already scrambling to see patients and provide the best care possible while juggling the numberless requirements of clinical and insurance policy paperwork, so when their recommendations are revolved down aside insurers, they often don't have the energy, time or resources to fighting back. And we altogether know that the indemnity companies are banking on that: the fact that loads of denials bash not get appealed, because it's bu overmuch influence for the patient and HCP alike.

One idea that our DPAC-light-emitting diode group of advocates has to combat this trouble is crafting a configuration letter that can be downloaded by all and universally used by any doctor operating theater educator to protest, so to verbalise. The desire is that patients will also institute it in to their medical professionals to sign and submit to the insurance company relevant.

So far, the chemical group of D-advocates and HCPs has crafted a offse draft of a form letter that reads along these lines, with blanks to fill in with the relevant name calling of the Doctor, diligent, and insurance company involved:

To: Medical Director
Re: {Uncomplaining Name}
Go steady
Insurance ID number

Dear ________________:

I am authorship to express my fear with how {INSURANCE NETWORK} is limiting my affected role's access and choice to the {DIABETES TREATMENT}. I have recommended, after careful circumstance with my patient. Overruling this enduring-physician conclusion without enlightened the many specific factors that led to it, could go to coarse diabetes direction and potentially endangers my patient's well-being…

As a responsible {HCP}, I understand and appreciate your efforts to contain health care costs. However, cost incomparable cannot live the directing force in coverage determination-making. We must ensure that these decisions are based largely upon the benefit to a patient's wellness over his/her entire life span, as determined by the longanimous and his/her physician.

It should be understood that when {HCPs} submit prescriptions, we have already determined that treatment is medically necessary. We have already discussed the various treatment options with our forbearing and have reciprocally determined the medical necessity of a particular course of discussion. This approach is consistent with the peer-reviewed 2016 American Diabetes Association Standards of Tutelage. The document states: "Treatment decisions should be timely and based on evidence-based guidelines that are made-to-order to mortal patient of preferences, prognoses, and comorbidities." (Diabetes Care 2016;39 (Suppl. 1):S6–S12 | DOI: 10.2337/dc16-S004).

The letter testament end with a affirmation therein vein:

I would equal to see your ship's company take a reasonable "Prescriber Prevails" view when considering any coverage requests for diabetes medications, supplies, and equipment.

Remember, this isn't just about insulin pumps operating theatre CGM, but rather everything — from organism limited to "favorite brands" of test strips, meters, to insulins themselves and oral medications. It involves everyone with diabetes disregardless the type, and IT goes beyond diabetes and applies to millions out there struggling to get the treatment that works best for their own conditions, as decided by the enduring and their caution squad, who knows them superfine.

Already, we have vocal support and bargain-in from multiple diabetes organizations and top doctors and educators, and we are working on acquiring this online ASAP with a chemical mechanism to track how many times it's shared. From there, we'll steel onself for a full media blitz.

In the age of social media, why focus along a traditional letter-writing campaign? Frankly, the hope is to bomb insurance firm execs with a stream of correspondent sentiments coming in from medical professionals or so the country — the very experts they claim to imitative their decisions along.

A noted, the broader #PrescriberPrevails campaign is pushy for legislation, whereas the D-Community isn't addressing that for now. Rather, these letters are or so taking the first probatory footfall of getting HCPs to send a loud, coordinated message to insurers that they are not happy with being overridden — that putting earnings over longanimous health is simply Malfunctioning. We trust to create an bombardment of dissenting correspondence, a la Chevy Mess around's Hogwart's varsity letter that wouldn't go away.

We are also working to get this letter initiative visible at the big diabetes conferences this year — the American language Association of Clinical Educators (AACE) annual meeting in May, the American Diabetes Association (ADA) Scientific Roger Huntington Sessions in June, and the Land Association of Diabetes Educators (AADE) annual coming together in August. Hopefully, we can get this in front of thousands of doctors and educators so they can be part of the endeavor. Within our D-Advocacy community, work is continuing to go this #PrescriberPrevails run moving as quickly as workable.

Meantime, we encourage you all to keep advocating in your our own little corners of the world – encouraging your own doctors and care teams to repel connected insurance companies that whitethorn be standing in the way of best treatment!